Tech Company Financing Transactions

Ikonisys Funding Round

Ikonisys, operating out of New Haven, received $30 million in funding from Goldman Sachs, New Science Ventures and Palisade Capital Management.

Transaction Overview

Company Name
Announced On
10/17/2007
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series E
Proceeds Purpose
Company CEO Dr. Petros Tsipouras said, "The additional capital provides Ikonisys with the support necessary to fulfill upcoming clinical milestones and further the development and launch of new proprietary tests within our oncoFISH and fastFISH product lines for the diagnosis and management of cancer and for women's health applications."

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5 Science Park
New Haven, CT 06511
USA
Email Address
Overview
Ikonisys pioneering technology and laboratory testing offers cancer diagnosis based on rare cancer cell detection.
Profile
Ikonisys LinkedIn Company Profile
Social Media
Ikonisys Company Twitter Account
Company News
Ikonisys News
Facebook
Ikonisys on Facebook
YouTube
Ikonisys on YouTube

Management Team

Title
Name
Email & Social
Founder
Michael Kilpatrick
  Michael Kilpatrick LinkedIn Profile  Michael Kilpatrick Twitter Account  Michael Kilpatrick News  Michael Kilpatrick on Facebook
VP - Operations
William Kochiss
  William Kochiss LinkedIn Profile  William Kochiss Twitter Account  William Kochiss News  William Kochiss on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/17/2007: The Climate Corporation venture capital transaction
Next: 10/18/2007: Vocalocity venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary